To compare the efficacy of two kinds of Zhizhu pills in the treatment of functional dyspepsia of spleen-deficiency and qi-stagnation syndrome:A randomized group sequential comparative trial

BMC Gastroenterology

Volumn 11, Issue , 2011, Pages

  Wu, Hongli ^a   Jing, Zhiwei ^a   Tang, Xudong ^a   Wang, Xinyue ^b   Zhang, Shengsheng ^c   Yu, Yanan ^a   Wang, Zhong ^a   Cao, Hongxin ^a   Huang, Luqi ^a   Yu, Youhua ^a   Wang, Yongyan ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b BEIJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHINESE DRUG; UNCLASSIFIED DRUG; ZHIZHU; HERBACEOUS AGENT;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CHINA; CHINESE MEDICINE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; QI STAGNATION SYNDROME; RANDOMIZED CONTROLLED TRIAL; SOUR ORANGE; SPLEEN DEFICIENCY SYNDROME; STATISTICAL ANALYSIS; SWEET ORANGE; CITRUS; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; MIDDLE AGED; PATHOLOGY; PHYTOTHERAPY; SPLEEN DISEASE; SYNDROME; TABLET; TREATMENT OUTCOME;

ADULT; CITRUS; CITRUS SINENSIS; DOUBLE-BLIND METHOD; DRUGS, CHINESE HERBAL; DYSPEPSIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYTOTHERAPY; QI; SPLENIC DISEASES; SYNDROME; TABLETS; TREATMENT OUTCOME;

EID: 79960565082     PISSN: None     EISSN: 1471230X     Source Type: Journal    
DOI: 10.1186/1471-230X-11-81     Document Type: Article

References (21)

1. Talley NJ, Stanghellini V, Heading RC. Functional gastroduodenal disorders. Gut 1999, 45:1137-1142.
2. Malfertheiner P. Current concepts in dyspepsia: a world perspective. Eur J Gastroenterol Hepatol 1999, 11(Suppl 1):RS25-29.
3. Spiller R. Rome II: the functional gastrointestinal disorders. diagnosis, pathophysiology and treatment: a multinational consensus. Gut 2000, 46:741.
4. El-Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther 2004, 19:643-654. 10.1111/j.1365-2036.2004.01897.x, 15023166.
5. Kang X, Liu Z, Xie B. The incidence of functional dyspepsia of parts of citizens in Tianjin. Chinese Journal of Digestion 2002, 22:191-192.
6. Zheng XY. Guiding principle of clinical research on new drugs of Chinese medicine in the treament of stuffiness and fullness. Guiding principle of clinical research on new drugs of Chinese medicine (trial implementation) 2002, 54-58. Bejing, Chinese Medical Science and Technology Press, Yu XH.
7. China Pharmacopoeia Committee Zhizhu Wan(Pills). Pharmacopoeia of the People's Republic of China 2005, I:778. Beijing, China Medical Science Press, China Pharmacopoeia Committee, English, China Pharmacopoeia Committee.
8. Whitehead J. The triangular test. The design and analysis of sequential clinical trials(Revised second Edition) 1997, 76-87. Chichester, John Wiley & Sons Ltd, Barnett V.
9. Whitehead J. Group sequential trials revisited:Simple implementation using SAS. Statistical Methods in Medical Research 2010, 1-22.
10. Rita B, Braden K. Functional dyspepsia. Ther Adv Gastroenterol 2010, 3:145-164.
11. Hansen JM, Bytzer P, Schaffalitzky de Muckadell OB. Placebo-controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia. Am J Gastroenterol 1998, 93:368-374. 10.1111/j.1572-0241.1998.00368.x, 9517642.
12. Talley NJ, Meineche-Schmidt V, Paré P. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998, 12:1055-1065. 10.1046/j.1365-2036.1998.00410.x, 9845395.
13. Talley NJ, Hunt RH. What role does Helicobacter pylori play in dyspepsia and nonulcer dyspepsia? Arguments for and against H. pylori being associated with dyspeptic symptoms. Gastroenterology 1997, 113:S67-77. 10.1016/S0016-5085(97)70081-7, 9394764.
14. Pu RT, Osmani SA. Mitotic destruction of the cell cycle regulated NIMA protein kinase of Aspergillus nidulans is required for mitotic exit. EMBO J 1995, 14:995-1003. 398171, 7889945.
15. Xijun W, Xi C, Hongxin C. Pharmacokinetic studies of naringenin and hesperetin in human plasma after oral administration of Zhizhu Wan. Chinese Journal of Experimental Traditional Medicine Formulae 2007, 3:18-20.
16. Anderson TW. A modification of the sequential probability ratio test to reduce the sample size. The Annals of Mathematical Statistics 1960, 31:165-197.
17. Whitehead J, Stratton I. Group sequential clinical trials with triangular continuation regions. Biometrics 1983, 39:227-236. 10.2307/2530822, 6871351.
18. Sebille V, Bellissant E. Comparison of four sequential methods allowing for early stopping of comparative clinical trials. Clin Sci 2000, 98:569-578. 10.1042/CS19990336, 10781388.
19. Bellissant E, Bénichou J, Chastang C. Design and analysis of phase II trials in oncology with a group sequential method, the triangular test. Therapie 1991, 46:21-27.
20. Lin T, Sheng-sheng Z, Hong-bing W. Clinical Research on the prescription of Invigorating spleen with regulating qi and promoting blood circulation in treating 50 cases of functional dyspepsia of spleen-deficiency and qi-stagnation syndrome. Chinese Journal of Information on Traditional Chinese Medicine 2005, 12:11-13.
21. Talley NJ, Ruff K, Jiang X. The Rome III Classification of dyspepsia: will it help research?. Dig Dis 2008, 26:203-209. 10.1159/000121347, 18463436.